MKL-Based Sample Enrichment and Customized Outcomes Enable Smaller AD Clinical Trials. - Chris Hinrichs; N. Maritza Dowling; Sterling C. Johnson; Vikas Singh (MLINI, 2011)

The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. - N. Maritza Dowling; Sterling C. Johnson; Carey E. Gleason; William J. Jagust (NeuroImage, 2015)

An analysis of factors predicting memory loss in Alzheimer's disease prevention. - Mingzhao Hu; Yifei Zhang; N. Maritza Dowling (IJCNN, 2017)